What is it about?
Diabetic dislipidemia has specifics and differences as compared with dislipidemia in patients without diabetes. Beside hypolipemic effects, even more important are the effects of statins on cardiovascular risk reduction that is increased in this patients cohort.
Featured Image
Why is it important?
Description of characteristics and connection between lipo and glycotohicity in diabetic dislipidemic patients and increased cardiovascular risk.
Perspectives
This publication has to be followed with the similar ones that analyze the added cardiovascular risk reduction in combination therapy, especially with ezetimibe, or in the light of new PCSK9 inchibitors.
Professor marija B Vavlukis
Ss' Cyril and Methodius University, in Skopje, Faculty of Medicine
Read the Original
This page is a summary of: Effects of High Intensity Statin Therapy in the Treatment of Diabetic Dyslipidemia in Patients with Coronary Artery Disease, Current Pharmaceutical Design, April 2018, Bentham Science Publishers,
DOI: 10.2174/1381612824666171227215708.
You can read the full text:
Contributors
The following have contributed to this page
